Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP450262.RA_Mwo_1Iw0VYQPPgUrlG-D16kZHN4i2zVvoY5UAZICBc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP450262.RA_Mwo_1Iw0VYQPPgUrlG-D16kZHN4i2zVvoY5UAZICBc130_assertion type Assertion NP450262.RA_Mwo_1Iw0VYQPPgUrlG-D16kZHN4i2zVvoY5UAZICBc130_head.
- NP450262.RA_Mwo_1Iw0VYQPPgUrlG-D16kZHN4i2zVvoY5UAZICBc130_assertion description "[Primary tumors of ganetespib-treated mice had significantly reduced levels of HIF-1? (but not HIF-2?) protein and of HIF-1 target gene mRNAs encoding proteins that play key roles in angiogenesis, metabolism, invasion, and metastasis, thereby providing a molecular basis for observed effects of the drug on the growth and metastasis of triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450262.RA_Mwo_1Iw0VYQPPgUrlG-D16kZHN4i2zVvoY5UAZICBc130_provenance.
- NP450262.RA_Mwo_1Iw0VYQPPgUrlG-D16kZHN4i2zVvoY5UAZICBc130_assertion evidence source_evidence_literature NP450262.RA_Mwo_1Iw0VYQPPgUrlG-D16kZHN4i2zVvoY5UAZICBc130_provenance.
- NP450262.RA_Mwo_1Iw0VYQPPgUrlG-D16kZHN4i2zVvoY5UAZICBc130_assertion SIO_000772 24248265 NP450262.RA_Mwo_1Iw0VYQPPgUrlG-D16kZHN4i2zVvoY5UAZICBc130_provenance.
- NP450262.RA_Mwo_1Iw0VYQPPgUrlG-D16kZHN4i2zVvoY5UAZICBc130_assertion wasDerivedFrom befree-20150227 NP450262.RA_Mwo_1Iw0VYQPPgUrlG-D16kZHN4i2zVvoY5UAZICBc130_provenance.
- NP450262.RA_Mwo_1Iw0VYQPPgUrlG-D16kZHN4i2zVvoY5UAZICBc130_assertion wasGeneratedBy ECO_0000203 NP450262.RA_Mwo_1Iw0VYQPPgUrlG-D16kZHN4i2zVvoY5UAZICBc130_provenance.